Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects (Q44520873)

3 December 2017

Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects (English)

1 reference

3 December 2017

0 references

6

1 reference

3 December 2017

8

Emmanuel Mignot

1 reference

3 December 2017

2

Beth Ripley

1 reference

3 December 2017

Ronald M Salomon

1

1 reference

3 December 2017

John S Kennedy

3

1 reference

3 December 2017

Benjamin Johnson

4

1 reference

3 December 2017

Dennis Schmidt

5

1 reference

3 December 2017

Seiji Nishino

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

Biological Psychiatry

1 reference

3 December 2017

54

1 reference

3 December 2017

96-104

1 reference

3 December 2017

2

1 reference

The role of corticotropin-releasing factor in depression and anxiety disorders.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Sleep and psychiatric disorders. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Hypersomnia and manic-depressive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Spinal descent of cerebrospinal fluid in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Disruption of the activity-rest cycle by MAOI treatment: dependence on light and a secondary visual pathway to the circadian pacemaker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Fos expression in orexin neurons varies with behavioral state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Hypocretin/orexin, sleep and narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Effects of orexins on the hypothalamic-pituitary-adrenal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

EEG sleep profiles and recurrent depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Centrally administered orexin/hypocretin activates HPA axis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Differential expression of orexin receptors 1 and 2 in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Reliability and validity of the symptoms of major depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

A commentary on the neurobiology of the hypocretin/orexin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Hypocretin (orexin) deficiency in human narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Treatment of insomnia in patients with mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Neurons containing hypocretin (orexin) project to multiple neuronal systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Potential mechanisms of the sleep therapies for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Structure and function of human prepro-orexin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The effects of antidepressants on the thyroid axis in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Dysregulation of neuroendocrine crossroads: depression, circadian rhythms and the retina--a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The role of hypocretins (orexins) in sleep regulation and narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Reduced number of hypocretin neurons in human narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Chronobiological theories of nonseasonal affective disorders and their implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

To eat or to sleep? Orexin in the regulation of feeding and wakefulness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Depression, sleep physiology, and antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

Loss of Glucocorticoid Fast Feedback in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

On the contribution of sleep wake physiology to the explanation and the treatment of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901740-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(02)01740-7

1 reference

3 December 2017

1 reference